← Leaderboards
Nicholas K Foreman
University Of Colorado Denver
$4,734,103
Attributed
$4,734,103
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $711.4K · FY2010–24$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,734,103 · 3
By mechanism
R01$4,734,103 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Regie Lyn Pastor Santos-Cortez$3,793,066
- Rajeev Vibhakar$7,603,339
- James V Degregori$21,700,379
- David R Grosshans$9,101,858
- Carol A Kruse$3,200,645
Others in their field
Top investigators on “Childhood Brain Neoplasm”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Gregory H Reaman · National Childhood Cancer Foundation$78,833,655
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,639,263
- Brad H. Pollock · University Of Florida$28,646,726
- John H Sampson · Duke University$19,879,816
- Arzu Onar-Thomas · St. Jude Children'S Research Hospital$17,206,154
Research focus
Childhood Brain NeoplasmDesignOperative Surgical ProceduresTumorChildExcisionMolecularNeoplastic CellRecurrenceSamplingBrain NeoplasmsEpendymomaPhenotypeCessation Of LifeChildhood EpendymomaCellsBaseCancer EtiologyMalignant NeoplasmsAutomobile DrivingInsightMedulloblastomaIn VitroChemotherapy
Grant awards (14)
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$337,922
R01 · FY2024 · CA · contact PI
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$348,592
R01 · FY2023 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$348,592
R01 · FY2023 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$348,592
R01 · FY2022 · CA · contact PI
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$348,592
R01 · FY2022 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$355,706
R01 · FY2021 · CA · contact PI
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$355,706
R01 · FY2021 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$355,706
R01 · FY2020 · CA · contact PI
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma$355,706
R01 · FY2020 · CA · contact PI
Investigation of a Novel Cancer Stem Cell Population in Ependymoma.$355,706
R01 · FY2019 · CA · contact PI
Molecular and Cellular Characterization of Prognostic Immune Response in Childhoo$289,474
R01 · FY2013 · CA · contact PI
Molecular and Cellular Characterization of Prognostic Immune Response in Childhoo$307,951
R01 · FY2012 · CA · contact PI
Molecular and Cellular Characterization of Prognostic Immune Response in Childhoo$307,951
R01 · FY2011 · CA · contact PI
Molecular and Cellular Characterization of Prognostic Immune Response in Childhoo$317,907
R01 · FY2010 · CA · contact PI